Parvaquone is a veterinary antiprotozoal agent classified as a naphthalenedione derivative, primarily used to treat theileriosis in cattle by disrupting the energy metabolism of the parasite. This category… Read more
Parvaquone is a veterinary antiprotozoal agent classified as a naphthalenedione derivative, primarily used to treat theileriosis in cattle by disrupting the energy metabolism of the parasite. This category provides access to high-quality reference standards for Parvaquone, including its active pharmaceutical ingredient, pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. Pharmaceutical and veterinary research laboratories rely on these materials for critical analytical testing, impurity profiling, and method validation during quality control procedures. By utilizing these precisely characterized reference materials, researchers can ensure accurate identification and quantification of the parent drug and its degradation products within complex biological or chemical matrices. These essential compounds support the rigorous standards required for verifying product efficacy and safety in veterinary pharmaceutical applications.